L&A continues to expand its Life Sciences practice, with the recent addition of three hires in the group. “Nathaniel, Wei, and Ioana have stellar backgrounds which dovetail well with our clients’ technologies,” commented Cathy McCarty, a Life Sciences partner and co-managing partner of the firm. “Adding new practitioners helps to maintain our technological currency, and these three bring a wonderful energy that complements our existing practice group,” added Diana Collazo, a Life Sciences partner.
Ioana Davies is an organic chemist, whose practice focuses on patent prosecution, portfolio analysis and management, and diligence in all areas of the life sciences. Prior to joining L&A, she was a medicinal chemist at Vertex Pharmaceuticals for 13 years, the last 8 of which were as a senior research scientist.
Ioana received a Ph.D. in Organic Chemistry from Yale University and she completed her postdoctoral fellowship in chemistry at California Institute of Technology. She earned an M.S. degree and a B.S., with honors, in chemistry from Babes-Bolyai University (Romania). Ioana is registered to practice before the U.S. Patent and Trademark Office, and is an inventor on 16 U.S. patents. She is the author of a number of scientific research articles published in well-known journals, including Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Organic Letters, and Journal of Organic Chemistry.
Nathaniel Schafheimer works with L&A’s biotechnology clients in all aspects of patent prosecution, including portfolio and diligence analyses. Immediately prior to joining L&A, Nathaniel was a Technical Advisor at Ropes & Gray in Boston. Prior to joining Ropes, he was a post-doctoral associate at Massachusetts Institute of Technology, where he developed online biology courses on the edX learning platform covering a wide array of life science topics.
Nathaniel received a Ph.D. in Biology from Massachusetts Institute of Technology. His doctoral research examined how ultraviolet light contributed to cataract development by monitoring the protein aggregation and structural conformation of human lens proteins. Nathaniel received both an M.S., summa cum laude, and a B.S., summa cum laude, from Brandeis University.
Wei Zhang has extensive knowledge in the areas of immunology, antibody protein and polynucleotide therapies. She works with clients ranging from multinational pharmaceutical companies to biotechnology start-ups on the preparation and prosecution of patent applications, freedom to operate and patentability analyses, and due diligence reviews. Prior to joining L&A, Wei worked as an in-house patent agent at Agenus, a pioneer immune-oncology company prior to joining L&A. She also interned at Boehringer Ingelheim and at the Yale University Office of Cooperative Research.
Wei received her Ph.D. in cell biology from Yale University. Her doctoral research was supervised by Dr. Peter Cresswell (member of the National Academy of Sciences), and focused on regulation of major histocompatability complex antigen presentation. She received her B.S. in biological science from Peking University, and is a J.D. Candidate (expected 2020) at Suffolk University Law School. Wei is registered to practice before the U.S. Patent and Trademark Office, and she is the lead author of scientific articles published in several journals, including Proceedings of the National Academy of Sciences of the United States of America and Journal of Biological Chemistry.
About Lando & Anastasi, LLP
Lando & Anastasi, LLP headquartered in Cambridge, Massachusetts, partners with clients to protect their innovations through effective intellectual property strategies. This partnership complements an emphasis on creative and strategic solutions guided by a solid understanding of each client’s business imperatives. Well versed in a wide range of industries including life sciences, software, cleantech, medical devices, chemical and electrical engineering, L&A attorneys counsel clients ranging from individuals to early-stage and venture-backed start-ups to small and large national and global corporations.